Company · Brampton, Ontario, Canada
Sanis Health Inc.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 494
- 377 authorized now
- Natural health products
- 2
- 1 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 644
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| ALENDRONATE | 02352966 | Marketed | |
| ALFUZOSIN | 02519844 | Marketed | |
| ALMOTRIPTAN | 02466821 | Marketed | |
| AMIODARONE | 02364336 | Marketed | |
| AMLODIPINE | 02331284 | Marketed | |
| AMLODIPINE | 02331292 | Marketed | |
| AMLODIPINE | 02478587 | Marketed | |
| AMOXICILLIN | 02352753 | Marketed | |
| AMOXICILLIN | 02352788 | Marketed | |
| AMOXICILLIN CAPSULES BP | 02525348 | Marketed | |
| AMOXICILLIN CAPSULES BP | 02525356 | Marketed | |
| AMOXICILLIN/CLAV | 02536021 | Marketed | |
| AMOXICILLIN/CLAV | 02536048 | Marketed | |
| ANASTROZOLE | 02442736 | Marketed | |
| APIXABAN | 02548879 | Marketed | |
| APIXABAN | 02548887 | Marketed | |
| ARIPIPRAZOLE | 02506688 | Marketed | |
| ARIPIPRAZOLE | 02506718 | Marketed | |
| ARIPIPRAZOLE | 02506726 | Marketed | |
| ARIPIPRAZOLE | 02506734 | Marketed | |
| ARIPIPRAZOLE | 02506750 | Marketed | |
| ARIPIPRAZOLE | 02506785 | Marketed | |
| ATOMOXETINE | 02467747 | Marketed | |
| ATOMOXETINE | 02467755 | Marketed | |
| ATOMOXETINE | 02467763 | Marketed | |
| ATOMOXETINE | 02467771 | Marketed | |
| ATOMOXETINE | 02467798 | Marketed | |
| ATOMOXETINE | 02467801 | Marketed | |
| ATOMOXETINE | 02467828 | Marketed | |
| ATORVASTATIN | 02348705 | Marketed | |
| ATORVASTATIN | 02348713 | Marketed | |
| ATORVASTATIN | 02348721 | Marketed | |
| ATORVASTATIN | 02348748 | Marketed | |
| ATOVAQUONE PROGUANIL | 02421429 | Marketed | |
| AZITHROMYCIN | 02330881 | Marketed | |
| BACLOFEN | 02287021 | Marketed | |
| BACLOFEN | 02287048 | Marketed | |
| BICALUTAMIDE | 02519178 | Marketed | |
| BISOPROLOL | 02391589 | Marketed | |
| BISOPROLOL | 02391597 | Marketed | |
| BUSPIRONE TABLETS | 02568128 | Marketed | |
| CANDESARTAN/HCTZ | 02394804 | Marketed | |
| CANDESARTAN/HCTZ | 02536064 | Marketed | |
| CAPECITABINE | 02514982 | Marketed | |
| CAPECITABINE | 02514990 | Marketed | |
| CARVEDILOL | 02364913 | Marketed | |
| CARVEDILOL | 02364921 | Marketed | |
| CARVEDILOL | 02364948 | Marketed | |
| CARVEDILOL | 02364956 | Marketed | |
| CELECOXIB | 02436299 | Marketed | |
| CELECOXIB | 02436302 | Marketed | |
| CEPHALEXIN | 02521253 | Marketed | |
| CEPHALEXIN | 02521261 | Marketed | |
| CETIRIZINE | 02515695 | Marketed | |
| CINACALCET | 02524880 | Marketed | |
| CIPROFLOXACIN | 02353318 | Marketed | |
| CIPROFLOXACIN | 02353326 | Marketed | |
| CITALOPRAM | 02353660 | Marketed | |
| CITALOPRAM | 02353679 | Marketed | |
| CITALOPRAM | 02445719 | Marketed | |
| CLARITHROMYCIN | 02466120 | Marketed | |
| CLARITHROMYCIN | 02466139 | Marketed | |
| CLINDAMYCIN | 02400529 | Marketed | |
| CLINDAMYCIN | 02400537 | Marketed | |
| CLOPIDOGREL | 02400553 | Marketed | |
| CYCLOBENZAPRINE | 02287064 | Marketed | |
| DAPAGLIFLOZIN | 02561328 | Marketed | |
| DAPAGLIFLOZIN | 02561336 | Marketed | |
| DESVENLAFAXINE | 02535106 | Marketed | |
| DESVENLAFAXINE | 02535114 | Marketed | |
| DILTIAZEM CD | 02400421 | Marketed | |
| DILTIAZEM CD | 02400448 | Marketed | |
| DILTIAZEM CD | 02400456 | Marketed | |
| DILTIAZEM CD | 02400464 | Marketed | |
| DILTIAZEM T | 02516101 | Marketed | |
| DILTIAZEM T | 02516128 | Marketed | |
| DILTIAZEM T | 02516136 | Marketed | |
| DILTIAZEM T | 02516144 | Marketed | |
| DILTIAZEM T | 02516152 | Marketed | |
| DOCUSATE SODIUM | 02426838 | Marketed | |
| DOMPERIDONE | 02350440 | Marketed | |
| DONEPEZIL | 02426846 | Marketed | |
| DONEPEZIL | 02426854 | Marketed | |
| DUTASTERIDE | 02443058 | Marketed | |
| ELETRIPTAN | 02511266 | Marketed | |
| ELETRIPTAN | 02511274 | Marketed | |
| ENALAPRIL | 02400650 | Marketed | |
| ENALAPRIL | 02400669 | Marketed | |
| ENALAPRIL | 02400677 | Marketed | |
| ENALAPRIL | 02400685 | Marketed | |
| ENTECAVIR | 02527154 | Marketed | |
| ESCITALOPRAM | 02430118 | Marketed | |
| ESCITALOPRAM | 02430126 | Marketed | |
| EZETIMIBE | 02431300 | Marketed | |
| FAMOTIDINE | 02351102 | Marketed | |
| FAMOTIDINE | 02351110 | Marketed | |
| FEBUXOSTAT | 02539837 | Marketed | |
| FINASTERIDE | 02445077 | Marketed | |
| FINASTERIDE | 02445085 | Marketed | |
| FLECAINIDE | 02534800 | Marketed | |
| FLECAINIDE | 02534819 | Marketed | |
| FLUCONAZOLE | 02517396 | Marketed | |
| FLUCONAZOLE | 02517418 | Marketed | |
| FLUCONAZOLE-150 | 02521229 | Marketed | |
| FLUOXETINE | 02286068 | Marketed | |
| FLUOXETINE | 02286076 | Marketed | |
| FOSINOPRIL | 02459388 | Marketed | |
| FOSINOPRIL | 02459396 | Marketed | |
| FROVATRIPTAN | 02535475 | Marketed | |
| GABAPENTIN | 02353245 | Marketed | |
| GABAPENTIN | 02353253 | Marketed | |
| GABAPENTIN | 02353261 | Marketed | |
| GABAPENTIN | 02431289 | Marketed | |
| GALANTAMINE ER | 02443015 | Marketed | |
| GALANTAMINE ER | 02443023 | Marketed | |
| GALANTAMINE ER | 02443031 | Marketed | |
| GLICLAZIDE | 02287072 | Marketed | |
| HYDRALAZINE | 02539802 | Marketed | |
| HYDRALAZINE | 02539810 | Marketed | |
| HYDRALAZINE | 02539829 | Marketed | |
| HYDROCHLOROTHIAZIDE | 02360594 | Marketed | |
| HYDROXYCHLOROQUINE | 02519348 | Marketed | |
| IMATINIB | 02504596 | Marketed | |
| IMATINIB | 02504618 | Marketed | |
| IRBESARTAN | 02372347 | Marketed | |
| IRBESARTAN | 02372371 | Marketed | |
| IRBESARTAN | 02372398 | Marketed | |
| LACOSAMIDE | 02512874 | Marketed | |
| LACOSAMIDE | 02512882 | Marketed | |
| LACOSAMIDE | 02512890 | Marketed | |
| LACOSAMIDE | 02512904 | Marketed | |
| LACTULOSE | 02412268 | Marketed | |
| LAMOTRIGINE | 02343010 | Marketed | |
| LAMOTRIGINE | 02343029 | Marketed | |
| LAMOTRIGINE | 02343037 | Marketed | |
| LANSOPRAZOLE | 02357682 | Marketed | |
| LANSOPRAZOLE | 02357690 | Marketed | |
| LEFLUNOMIDE | 02351668 | Marketed | |
| LEFLUNOMIDE | 02351676 | Marketed | |
| LETROZOLE | 02504472 | Marketed | |
| LEVETIRACETAM | 02353342 | Marketed | |
| LEVETIRACETAM | 02353350 | Marketed | |
| LEVETIRACETAM | 02353369 | Marketed | |
| LISINOPRIL (TYPE Z) | 02525186 | Marketed | |
| LISINOPRIL (TYPE Z) | 02525194 | Marketed | |
| LISINOPRIL (TYPE Z) | 02525208 | Marketed | |
| LISINOPRIL/HCTZ (TYPE Z) | 02362945 | Marketed | |
| LISINOPRIL/HCTZ (TYPE Z) | 02362953 | Marketed | |
| LISINOPRIL/HCTZ (TYPE Z) | 02362961 | Marketed | |
| LOSARTAN | 02388863 | Marketed | |
| LOSARTAN | 02388871 | Marketed | |
| LOSARTAN | 02388898 | Marketed | |
| LOSARTAN/HCTZ | 02427648 | Marketed | |
| LOSARTAN/HCTZ | 02427656 | Marketed | |
| LOSARTAN/HCTZ | 02427664 | Marketed | |
| LURASIDONE | 02548585 | Marketed | |
| LURASIDONE | 02548593 | Marketed | |
| LURASIDONE | 02548607 | Marketed | |
| LURASIDONE | 02548615 | Marketed | |
| MELOXICAM | 02353148 | Marketed | |
| MELOXICAM | 02353156 | Marketed | |
| MEMANTINE | 02443082 | Marketed | |
| METFORMIN | 02353377 | Marketed | |
| METFORMIN | 02353385 | Marketed | |
| METFORMIN ER | 02558785 | Marketed | |
| METFORMIN ER | 02558793 | Marketed | |
| METOPROLOL | 02350394 | Marketed | |
| METOPROLOL | 02350408 | Marketed | |
| METRONIDAZOLE | 02534592 | Marketed | |
| MIDODRINE | 02533200 | Marketed | |
| MIDODRINE | 02533219 | Marketed | |
| MIRTAZAPINE | 02370689 | Marketed | |
| MIRTAZAPINE | 02532689 | Marketed | |
| MODAFINIL | 02530244 | Marketed | |
| MOMETASONE | 02519127 | Marketed | |
| MONTELUKAST | 02379325 | Marketed | |
| MONTELUKAST | 02379333 | Marketed | |
| MOXIFLOXACIN | 02520710 | Marketed | |
| MOXIFLOXACIN | 02529076 | Marketed | |
| MYCOPHENOLATE MOFETIL | 02457369 | Marketed | |
| MYCOPHENOLATE MOFETIL | 02457377 | Marketed | |
| OLANZAPINE | 02372819 | Marketed | |
| OLANZAPINE | 02372827 | Marketed | |
| OLANZAPINE | 02372835 | Marketed | |
| OLANZAPINE | 02372843 | Marketed | |
| OLANZAPINE | 02372851 | Marketed | |
| OLANZAPINE ODT | 02352974 | Marketed | |
| OLANZAPINE ODT | 02352982 | Marketed | |
| OLANZAPINE ODT | 02352990 | Marketed | |
| OLMESARTAN | 02481057 | Marketed | |
| OLMESARTAN | 02481065 | Marketed | |
| OLMESARTAN/HCTZ | 02509601 | Marketed | |
| OLMESARTAN/HCTZ | 02509628 | Marketed | |
| OLMESARTAN/HCTZ | 02509636 | Marketed | |
| OLOPATADINE | 02521172 | Marketed | |
| OLOPATADINE 0.2% | 02541653 | Marketed | |
| OMEPRAZOLE | 02348691 | Marketed | |
| ONDANSETRON | 02421402 | Marketed | |
| ONDANSETRON | 02421410 | Marketed | |
| ONDANSETRON ODT | 02524279 | Marketed | |
| ONDANSETRON ODT | 02524287 | Marketed | |
| PANTOPRAZOLE | 02370808 | Marketed | |
| PANTOPRAZOLE | 02536137 | Marketed | |
| PANTOPRAZOLE T | 02466147 | Marketed | |
| PAROXETINE | 02282844 | Marketed | |
| PAROXETINE | 02282852 | Marketed | |
| PAROXETINE | 02282860 | Marketed | |
| PERINDOPRIL ERBUMINE | 02481634 | Marketed | |
| PERINDOPRIL ERBUMINE | 02481642 | Marketed | |
| PERINDOPRIL ERBUMINE | 02481650 | Marketed | |
| PERINDOPRIL/INDAPAMIDE | 02519720 | Marketed | |
| PERINDOPRIL/INDAPAMIDE | 02519739 | Marketed | |
| PRAMIPEXOLE | 02367602 | Marketed | |
| PRAMIPEXOLE | 02367610 | Marketed | |
| PRAMIPEXOLE | 02367629 | Marketed | |
| PRAVASTATIN | 02356546 | Marketed | |
| PRAVASTATIN | 02356554 | Marketed | |
| PRAVASTATIN | 02356562 | Marketed | |
| PREGABALIN | 02405539 | Marketed | |
| PREGABALIN | 02405547 | Marketed | |
| PREGABALIN | 02405555 | Marketed | |
| PREGABALIN | 02405563 | Marketed | |
| PREGABALIN | 02405598 | Marketed | |
| PROGESTERONE | 02516187 | Marketed | |
| PRUCALOPRIDE | 02559005 | Marketed | |
| PRUCALOPRIDE | 02559013 | Marketed | |
| QUETIAPINE | 02353164 | Marketed | |
| QUETIAPINE | 02353172 | Marketed | |
| QUETIAPINE | 02353199 | Marketed | |
| QUETIAPINE | 02353202 | Marketed | |
| RABEPRAZOLE EC | 02356511 | Marketed | |
| RABEPRAZOLE EC | 02356538 | Marketed | |
| RISEDRONATE | 02370255 | Marketed | |
| RISEDRONATE | 02528460 | Marketed | |
| RISPERIDONE | 02356880 | Marketed | |
| RISPERIDONE | 02356899 | Marketed | |
| RISPERIDONE | 02356902 | Marketed | |
| RISPERIDONE | 02356910 | Marketed | |
| RISPERIDONE | 02356929 | Marketed | |
| RISPERIDONE | 02356937 | Marketed | |
| RIVAROXABAN | 02547899 | Marketed | |
| RIVAROXABAN | 02547902 | Marketed | |
| RIVAROXABAN | 02547910 | Marketed | |
| RIVAROXABAN | 02547929 | Marketed | |
| RIZATRIPTAN | 02516756 | Marketed | |
| RIZATRIPTAN ODT | 02442906 | Marketed | |
| RIZATRIPTAN ODT | 02442914 | Marketed | |
| ROSUVASTATIN | 02405628 | Marketed | |
| ROSUVASTATIN | 02405636 | Marketed | |
| ROSUVASTATIN | 02405644 | Marketed | |
| ROSUVASTATIN | 02405652 | Marketed | |
| SALBUTAMOL HFA | 02419858 | Marketed | |
| SERTRALINE | 02353520 | Marketed | |
| SERTRALINE | 02353539 | Marketed | |
| SERTRALINE | 02353547 | Marketed | |
| SILDENAFIL | 02406152 | Marketed | |
| SILDENAFIL | 02406160 | Marketed | |
| SILDENAFIL | 02540770 | Marketed | |
| SIMVASTATIN | 02284723 | Marketed | |
| SIMVASTATIN | 02284731 | Marketed | |
| SIMVASTATIN | 02284758 | Marketed | |
| SIMVASTATIN | 02284766 | Marketed | |
| SIMVASTATIN | 02284774 | Marketed | |
| SITAGLIPTIN | 02548550 | Marketed | |
| SITAGLIPTIN | 02548569 | Marketed | |
| SITAGLIPTIN | 02548577 | Marketed | |
| SITAGLIPTIN/METFORMIN | 02560445 | Marketed | |
| SITAGLIPTIN/METFORMIN | 02560453 | Marketed | |
| SITAGLIPTIN/METFORMIN | 02560461 | Marketed | |
| SOLIFENACIN | 02458241 | Marketed | |
| SOLIFENACIN | 02458268 | Marketed | |
| SUMATRIPTAN | 02286521 | Marketed | |
| SUMATRIPTAN | 02286548 | Marketed | |
| TADALAFIL | 02457016 | Marketed | |
| TADALAFIL | 02457024 | Marketed | |
| TADALAFIL | 02457032 | Marketed | |
| TAMSULOSIN CR | 02427117 | Marketed | |
| TELMISARTAN | 02388944 | Marketed | |
| TELMISARTAN | 02388952 | Marketed | |
| TELMISARTAN/HCTZ | 02395355 | Marketed | |
| TELMISARTAN/HCTZ | 02395363 | Marketed | |
| TENOFOVIR | 02512327 | Marketed | |
| TOPIRAMATE | 02356856 | Marketed | |
| TOPIRAMATE | 02356864 | Marketed | |
| TOPIRAMATE | 02356872 | Marketed | |
| TRANDOLAPRIL | 02525046 | Marketed | |
| TRANDOLAPRIL | 02525054 | Marketed | |
| TRANDOLAPRIL | 02525070 | Marketed | |
| TRAZODONE | 02348772 | Marketed | |
| TRAZODONE | 02348780 | Marketed | |
| TRAZODONE | 02348799 | Marketed | |
| VALACYCLOVIR | 02454645 | Marketed | |
| VALACYCLOVIR | 02519585 | Marketed | |
| VALSARTAN | 02366940 | Marketed | |
| VALSARTAN | 02366959 | Marketed | |
| VALSARTAN | 02366967 | Marketed | |
| VALSARTAN | 02366975 | Marketed | |
| VALSARTAN HCT | 02367009 | Marketed | |
| VALSARTAN HCT | 02367017 | Marketed | |
| VALSARTAN HCT | 02367025 | Marketed |
Showing 300 of 494 drug products. For the rest, search Health Canada’s database.
Natural health products
Active licences first, newest first.
| Name | NPN | Status | Licensed |
|---|---|---|---|
| CALCIUM/VIT D 500MG/400IU | 80053666 | Active | |
| CALCIUM CARBONATE | 80062015 | Discontinued |
Notices of Compliance
Newest first.
- RAMIPRIL CAPSULESOctober 9, 2026 · NOC 38448 · Abbreviated New Drug Submission (ANDS)
- BILASTINEOctober 6, 2026 · NOC 38419 · Abbreviated New Drug Submission (ANDS)
- EZETIMIBEOctober 2, 2026 · NOC 38398 · Abbreviated New Drug Submission (ANDS)
- ESOMEPRAZOLESeptember 11, 2026 · NOC 38274 · Abbreviated New Drug Submission (ANDS)
- CLOPIDOGRELSeptember 10, 2026 · NOC 38273 · Abbreviated New Drug Submission (ANDS)
- FLECAINIDESeptember 9, 2026 · NOC 38255 · Supplement to an Abbreviated New Drug Submission (SANDS)
- CANDESARTANSeptember 1, 2026 · NOC 38221 · Abbreviated New Drug Submission (ANDS)
- IMATINIBAugust 21, 2026 · NOC 38154 · Supplement to an Abbreviated New Drug Submission (SANDS)
- BIMATOPROST RCAugust 19, 2026 · NOC 38138 · Abbreviated New Drug Submission (ANDS)
- CYCLOBENZAPRINEAugust 19, 2026 · NOC 38145 · Supplement to a New Drug Submission (SNDS)
- PROGESTERONEAugust 12, 2026 · NOC 38089 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ZOPICLONEAugust 7, 2026 · NOC 38076 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PERINDOPRIL/INDAPAMIDEAugust 6, 2026 · NOC 38067 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MYCOPHENOLATE MOFETILAugust 5, 2026 · NOC 38055 · Supplement to an Abbreviated New Drug Submission (SANDS)
- CITALOPRAMAugust 4, 2026 · NOC 38032 · Supplement to an Abbreviated New Drug Submission (SANDS)
- RIVAROXABANJuly 28, 2026 · NOC 38001 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SUMATRIPTANJuly 23, 2026 · NOC 37986 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ESCITALOPRAMJuly 21, 2026 · NOC 37954 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DULOXETINEJuly 17, 2026 · NOC 37920 · Supplement to an Abbreviated New Drug Submission (SANDS)
- HYDROXYCHLOROQUINEJune 30, 2026 · NOC 37807 · Supplement to an Abbreviated New Drug Submission (SANDS)
- BISOPROLOLJune 29, 2026 · NOC 37791 · Supplement to an Abbreviated New Drug Submission (SANDS)
- LANSOPRAZOLE; LANSOPRAZOLE FDTJune 26, 2026 · NOC 37796 · Abbreviated New Drug Submission (ANDS)
- DIENOGESTJune 19, 2026 · NOC 37733 · Abbreviated New Drug Submission (ANDS)
- DILTIAZEM CDJune 16, 2026 · NOC 37710 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRUCALOPRIDEJune 11, 2026 · NOC 37690 · Supplement to an Abbreviated New Drug Submission (SANDS)
- FLECAINIDEMay 29, 2026 · NOC 37630 · Supplement to an Abbreviated New Drug Submission (SANDS)
- HYDRALAZINEMay 29, 2026 · NOC 37636 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AMIODARONEMay 26, 2026 · NOC 37612 · Abbreviated New Drug Submission (ANDS)
- FAMOTIDINE TABLETSMay 25, 2026 · NOC 37600 · Abbreviated New Drug Submission (ANDS)
- GABAPENTINMay 22, 2026 · NOC 37589 · Supplement to an Abbreviated New Drug Submission (SANDS)
- CAPECITABINEMay 12, 2026 · NOC 37520 · Supplement to an Abbreviated New Drug Submission (SANDS)
- BUSPIRONE TABLETSMay 7, 2026 · NOC 37504 · Abbreviated New Drug Submission (ANDS)
- IRBESARTANMay 1, 2026 · NOC 37451 · Supplement to an Abbreviated New Drug Submission (SANDS)
- GLICLAZIDE MR TABLETSMay 1, 2026 · NOC 37457 · Abbreviated New Drug Submission (ANDS)
- ATORVASTATINApril 29, 2026 · NOC 37434 · Supplement to an Abbreviated New Drug Submission (SANDS)
- METFORMIN ERApril 24, 2026 · NOC 37395 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ATENOLOL TABLETSApril 13, 2026 · NOC 37312 · Abbreviated New Drug Submission (ANDS)
- ATENOLOL TABLETSApril 9, 2026 · NOC 37286 · New Drug Submission (NDS)
- CELECOXIBApril 9, 2026 · NOC 37297 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ALENDRONATEApril 7, 2026 · NOC 37278 · Supplement to an Abbreviated New Drug Submission (SANDS)
- LEFLUNOMIDEMarch 26, 2026 · NOC 37186 · Supplement to an Abbreviated New Drug Submission (SANDS)
- TOPIRAMATEMarch 25, 2026 · NOC 37185 · Supplement to an Abbreviated New Drug Submission (SANDS)
- METFORMIN TABLETSMarch 23, 2026 · NOC 37165 · Abbreviated New Drug Submission (ANDS)
- SALBUTAMOL HFAMarch 20, 2026 · NOC 37139 · Supplement to a New Drug Submission (SNDS)
- HYDROCHLOROTHIAZIDEMarch 18, 2026 · NOC 37125 · Abbreviated New Drug Submission (ANDS)
- GABAPENTINMarch 11, 2026 · NOC 37077 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AMOXICILLIN CAPSULES BPMarch 9, 2026 · NOC 37068 · Supplement to an Abbreviated New Drug Submission (SANDS)
- LAMOTRIGINEMarch 3, 2026 · NOC 37016 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ESOMEPRAZOLEFebruary 23, 2026 · NOC 36947 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SILODOSINFebruary 20, 2026 · NOC 36946 · Abbreviated New Drug Submission (ANDS)
- TERBINAFINEFebruary 9, 2026 · NOC 36865 · Abbreviated New Drug Submission (ANDS)
- CYCLOBENZAPRINEFebruary 4, 2026 · NOC 36841 · New Drug Submission (NDS)
- DILTIAZEM TFebruary 2, 2026 · NOC 36811 · Supplement to an Abbreviated New Drug Submission (SANDS)
- IRBESARTAN/HCTZJanuary 21, 2026 · NOC 36756 · Abbreviated New Drug Submission (ANDS)
- ARIPIPRAZOLEJanuary 13, 2026 · NOC 36720 · Supplement to an Abbreviated New Drug Submission (SANDS)
- CETIRIZINEJanuary 12, 2026 · NOC 36765 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DONEPEZILJanuary 2, 2026 · NOC 36657 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRAVASTATINJanuary 2, 2026 · NOC 36661 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ANASTROZOLEDecember 10, 2025 · NOC 36511 · Supplement to an Abbreviated New Drug Submission (SANDS)
- APIXABANNovember 25, 2025 · NOC 36419 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AMOXICILLIN; AMOXICILLIN (REDUCED-SUGAR)November 13, 2025 · NOC 36363 · Supplement to a New Drug Submission (SNDS)
- DAPAGLIFLOZINOctober 29, 2025 · NOC 36281 · Abbreviated New Drug Submission (ANDS)
- HYDROXYCHLOROQUINEOctober 21, 2025 · NOC 36218 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ROSUVASTATINSeptember 25, 2025 · NOC 36059 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SITAGLIPTIN/METFORMINAugust 18, 2025 · NOC 35851 · Abbreviated New Drug Submission (ANDS)
- DUTASTERIDEAugust 13, 2025 · NOC 35828 · Abbreviated New Drug Submission (ANDS)
- RISEDRONATEJuly 31, 2025 · NOC 35776 · Supplement to an Abbreviated New Drug Submission (SANDS)
- TERBINAFINEJuly 25, 2025 · NOC 35745 · Supplement to an Abbreviated New Drug Submission (SANDS)
- CLARITHROMYCINJuly 23, 2025 · NOC 35715 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRUCALOPRIDEJuly 3, 2025 · NOC 35613 · Abbreviated New Drug Submission (ANDS)
- GLICLAZIDEJune 30, 2025 · NOC 35601 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DULOXETINEJune 24, 2025 · NOC 35558 · Supplement to an Abbreviated New Drug Submission (SANDS)
- METFORMIN ERJune 24, 2025 · NOC 35560 · Abbreviated New Drug Submission (ANDS)
- METFORMIN ERJune 24, 2025 · NOC 35561 · Abbreviated New Drug Submission (ANDS)
- AMOXICILLIN/CLAVJune 10, 2025 · NOC 35495 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AMOXICILLIN; AMOXICILLIN (SUGAR REDUCED)May 30, 2025 · NOC 35454 · Supplement to a New Drug Submission (SNDS)
- ZOPICLONEMay 27, 2025 · NOC 35434 · Supplement to an Abbreviated New Drug Submission (SANDS)
- TELMISARTAN/HCTZMay 1, 2025 · NOC 35276 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PREGABALINApril 1, 2025 · NOC 35105 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SILDENAFILMarch 27, 2025 · NOC 35080 · Supplement to an Abbreviated New Drug Submission (SANDS)
- RIVAROXABANMarch 19, 2025 · NOC 35031 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MIRTAZAPINEMarch 18, 2025 · NOC 35035 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DESVENLAFAXINEFebruary 27, 2025 · NOC 34912 · Supplement to an Abbreviated New Drug Submission (SANDS)
- GALANTAMINE ERFebruary 27, 2025 · NOC 34922 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRAMIPEXOLEFebruary 11, 2025 · NOC 34824 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DONEPEZILFebruary 4, 2025 · NOC 34788 · Abbreviated New Drug Submission (ANDS)
- ZOLMITRIPTAN; ZOLMITRIPTAN ODTFebruary 3, 2025 · NOC 34783 · Supplement to an Abbreviated New Drug Submission (SANDS)
- EZETIMIBEJanuary 30, 2025 · NOC 34764 · Supplement to an Abbreviated New Drug Submission (SANDS)
- FINASTERIDEJanuary 23, 2025 · NOC 34732 · Supplement to an Abbreviated New Drug Submission (SANDS)
- CETIRIZINEJanuary 23, 2025 · NOC 34746 · Abbreviated New Drug Submission (ANDS)
- GABAPENTINJanuary 9, 2025 · NOC 34649 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ONDANSETRON ODTDecember 9, 2024 · NOC 34523 · Abbreviated New Drug Submission (ANDS)
- PRAVASTATINDecember 5, 2024 · NOC 34498 · Abbreviated New Drug Submission (ANDS)
- CLINDAMYCINDecember 5, 2024 · NOC 34499 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ATORVASTATINDecember 4, 2024 · NOC 34491 · Abbreviated New Drug Submission (ANDS)
- LAMOTRIGINENovember 28, 2024 · NOC 34459 · Supplement to an Abbreviated New Drug Submission (SANDS)
- LISINOPRIL/HCTZ (TYPE Z)November 19, 2024 · NOC 34417 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DILTIAZEM CDNovember 15, 2024 · NOC 34392 · Supplement to an Abbreviated New Drug Submission (SANDS)
- LISINOPRIL (TYPE Z)November 1, 2024 · NOC 34317 · Abbreviated New Drug Submission (ANDS)
- DOMPERIDONENovember 1, 2024 · NOC 34319 · Supplement to a New Drug Submission (SNDS)
The latest 100 of 644.